Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Oxford Centre for Microbiome Studies (OCMS) provides unique access to essential technologies to speed up our understanding of how the microbes that inhabit our bodies influence health and disease.

None

Imbalances in the complex communities of bacteria that inhabit our bodies have been linked to a range of chronic diseases, but we still don’t know how different types of bacteria interact with body systems. The OCMS opens up the Kennedy Institute’s germ-free facility and other state-of-the-art technologies enabling complete analysis of the microbiome.

Professor Fiona Powrie who leads the Centre, says “Our new germ-free facility provides essential technology to move beyond association studies to identify functional pathways through which microbes communicate with their hosts. This knowledge will help us harness the power of the microbiome to promote health and prevent disease”.

The Centre comprises a team of 16 researchers spanning eight University departments creating a community of interdisciplinary researchers to galvanise and innovate research in this area. Through the provision of resources to the community in both a service and collaborative capacity, the OCMS establishes a hub for microbiome science to generate deeper insights into the role of microbes across diverse environments and disease settings.  

Scientific Project Manager, Dr Paula Colmenero, who provides day-to-day management of the Centre said, “It is exciting to see how the Centre is growing. We have already engaged in a number of studies with scientists from various departments coming to us to establish collaborations or seek help with their microbiome projects. In addition to infrastructure, the Centre also provides expertise, from study design through experimental setup to bioinformatics data analysis. We have also organised a microbiome interest group that will act as a platform for scientists to meet and discuss microbiome research”.

The Centre is supported by the Kennedy Trust for Rheumatology Research and Wellcome Trust Institutional Strategic Support.

 To learn more, please visit the OCMS website or contact ocms@kennedy.ox.ac.uk.

 

 

Similar stories

T-cell coreceptors are well endowed—with kinases!

The kinase occupancy of CD4 and CD8 coreceptors is high, according to a new study published in PNAS.

Two prestigious Hunterian Professorships awarded to NDORMS researchers

Conrad Harrison and Tom Layton have both been awarded Hunterian Professorships for 2022 by the Royal College of Surgeons of England

Dr Alex Clarke wins Emerging Leaders Prize for lupus research

Alex is one of three exceptional lupus researchers that have been announced as winners of the Medical Research Foundation’s sixth Emerging Leaders Prize.

Adalimumab is found to be a cost-effective treatment for early-stage Dupuytren’s disease

Researchers at the Kennedy Institute of Rheumatology and Oxford Population Health’s Health Economics Research Centre have found that anti-TNF treatment (adalimumab) is likely to be a cost-effective treatment for people affected by early-stage Dupuytren’s disease.

Patients like me

What can patients learn from the experiences of people like them who’ve already had a hip replacement? A new tool called ‘Patients like me’ helps answer some of the questions about pain, complications and how long the prosthesis might last.

Study reveals new evidence on rare blood-clotting condition after covid-19 vaccination

Researchers from NDORMS at the University of Oxford have investigated claims that some adenovirus-based COVID-19 vaccines increase the risk of rare blood clots compared to their mRNA-based counterparts.